Eickhoff, M.K.;                     Dekkers, C.C.J.;                     Kramers, B.J.;                     Laverman, G.D.;                     Frimodt-Møller, M.;                     Jørgensen, N.R.;                     Faber, J.;                     Danser, A.H.J.;                     Gansevoort, R.T.;                     Rossing, P.;     
    et al.    Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors. J. Clin. Med. 2019, 8, 779.
    https://doi.org/10.3390/jcm8060779
    AMA Style
    
                                Eickhoff MK,                                 Dekkers CCJ,                                 Kramers BJ,                                 Laverman GD,                                 Frimodt-Møller M,                                 Jørgensen NR,                                 Faber J,                                 Danser AHJ,                                 Gansevoort RT,                                 Rossing P,         
        et al.        Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors. Journal of Clinical Medicine. 2019; 8(6):779.
        https://doi.org/10.3390/jcm8060779
    
    Chicago/Turabian Style
    
                                Eickhoff, Mie K.,                                 Claire C. J. Dekkers,                                 Bart J. Kramers,                                 Gozewijn Dirk Laverman,                                 Marie Frimodt-Møller,                                 Niklas Rye Jørgensen,                                 Jens Faber,                                 A. H. Jan Danser,                                 Ron T. Gansevoort,                                 Peter Rossing,         
         and et al.        2019. "Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors" Journal of Clinical Medicine 8, no. 6: 779.
        https://doi.org/10.3390/jcm8060779
    
    APA Style
    
                                Eickhoff, M. K.,                                 Dekkers, C. C. J.,                                 Kramers, B. J.,                                 Laverman, G. D.,                                 Frimodt-Møller, M.,                                 Jørgensen, N. R.,                                 Faber, J.,                                 Danser, A. H. J.,                                 Gansevoort, R. T.,                                 Rossing, P.,                                 Persson, F.,                                 & Heerspink, H. J. L.        
        
        (2019). Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors. Journal of Clinical Medicine, 8(6), 779.
        https://doi.org/10.3390/jcm8060779